<qa>  What is the STUDY OF DULANERMIN ADMINISTERED IN COA STUDY OF DULANERMIN ADMINISTERED IN COMBINATION WITH THE FOLFOX REGIMEN AND BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED, LOCALLY ADVANCED, RECURRENT, OR METASTATIC COLORECTAL CANCER: 